In this episode, Greg and Andy speak with William Abecassis, managing partner and chief investment officer at BRAVEN, about how he broke into the field of VC and founded his own firm. William also shares his process of vetting early-stage companies like Exo and his thoughts on the future of the IPO market.

This is our final episode of Inside the Exo Chamber for this season. Thanks for joining us, and be sure to follow us on LinkedIn for updates on when we’ll be back!

This month, Greg and Andy connect with Exo’s Vice President of Artificial Intelligence, Dornoosh Zonoobi, for a conversation all about artificial intelligence (AI) in healthcare. Dornoosh shares her thoughts on bias in AI, how she’s personally working to remove it, and how the innovative technology will help transform the healthcare industry. Dornoosh also shares her experience as co-founder & CEO of Medo.ai, a health-tech startup focused on developing cutting-edge AI technologies to simplify the use of ultrasound, that was acquired by Exo in 2022.

Please rate and review the podcast and tune in next month for a new episode.

Follow Andy and Greg (@miller_pocus) on Twitter and connect with Dornoosh on LinkedIn.  

This month, Exo’s favorite duo, Andy and Greg, connect with Dave deBronkart, known as “e-Patient Dave,” who is a keynote speaker, author, kidney cancer survivor and leading activist in the patient engagement space. The trio discuss Dave’s experience being diagnosed with and battling cancer, specifically how sharing medical information and general knowledge helped improve his odds of survival. After writing about his recovery, Dave has become a leader in patient empowerment, and continues to advocate for sharing knowledge with the goal of improving the American healthcare system.

Please rate and review the podcast and tune in next month for a new episode.

Follow Andy and Greg on Twitter and connect with Dave on LinkedIn.